Cassava Sciences' Simufilam Trial Faces Fresh FDA Scrutiny
A Glimmer of Hope? Alzheimer's Drug Shows Remarkable Promise in Mice
Cassava Sciences Soars: CEO's Insider Buy Signals Confidence After Federal Clearance